GILD
Gilead Sciences, Inc.
- Capital expenditures, 2025
- $563M
- YoY, 2025
- +7.6%
- 5-year CAGR
- −2.8%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $563M | +7.6% |
| 2024 | $523M | −10.6% |
| 2023 | $585M | −19.6% |
| 2022 | $728M | +25.7% |
| 2021 | $579M | −10.9% |
| 2020 | $650M | −21.2% |
| 2019 | $825M | −10.7% |
| 2018 | $924M | — |
| 2013 | $134M | — |